202 related articles for article (PubMed ID: 18830521)
1. The use of microspirometry in detecting lowered FEV1 values in current or former cigarette smokers.
Rytila P; Helin T; Kinnula V
Prim Care Respir J; 2008 Dec; 17(4):232-7. PubMed ID: 18830521
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study.
van den Bemt L; Wouters BC; Grootens J; Denis J; Poels PJ; Schermer TR
NPJ Prim Care Respir Med; 2014 Aug; 24():14033. PubMed ID: 25119686
[TBL] [Abstract][Full Text] [Related]
3. Voluntary lung function screening to reveal new COPD cases in southern Italy.
Capozzolo A; Castellana G; Dragonieri S; Carratù P; Liotino V; Vulpi MR; Marra L; Resta E; Intiglietta P; Resta O
Int J Chron Obstruct Pulmon Dis; 2017; 12():2035-2042. PubMed ID: 28744118
[TBL] [Abstract][Full Text] [Related]
4. Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study.
López Varela MV; Montes de Oca M; Rey A; Casas A; Stirbulov R; Di Boscio V;
Respirology; 2016 Oct; 21(7):1227-34. PubMed ID: 27319305
[TBL] [Abstract][Full Text] [Related]
5. [Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care].
Clotet J; Gómez-Arbonés X; Ciria C; Albalad JM
Arch Bronconeumol; 2004 Apr; 40(4):155-9. PubMed ID: 15030729
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies.
Sansores RH; Ramírez-Venegas A; Hernández-Zenteno R; Mayar-Maya ME; Pérez-Bautista OG; Velázquez Uncal M
Respir Med; 2013 Apr; 107(4):580-6. PubMed ID: 23313037
[TBL] [Abstract][Full Text] [Related]
7. Fixed ratio or lower limit of normal for the FEV
Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
[TBL] [Abstract][Full Text] [Related]
8. Which is the Best Screening Strategy for COPD among Smokers in Primary Care?
Llordés M; Zurdo E; Jaén Á; Vázquez I; Pastrana L; Miravitlles M
COPD; 2017 Feb; 14(1):43-51. PubMed ID: 27797591
[TBL] [Abstract][Full Text] [Related]
9. Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care?
Kjeldgaard P; Lykkegaard J; Spillemose H; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2017; 12():2323-2331. PubMed ID: 28831249
[TBL] [Abstract][Full Text] [Related]
10. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
11. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
12. Point of care microspirometry to facilitate the COPD diagnostic process in primary care: a clustered randomised trial.
Schermer TR; Vatsolaki M; Behr R; Grootens J; Cretier R; Akkermans R; Denis J; Poels P; van den Bemt L
NPJ Prim Care Respir Med; 2018 May; 28(1):17. PubMed ID: 29789607
[TBL] [Abstract][Full Text] [Related]
13. [Early detection of COPD in smoking cessation outpatients].
Rouatbi S; Mezghani S; Khalfallah M; Benzarti M
Tunis Med; 2015 Jul; 93(7):458-64. PubMed ID: 26757504
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of a pocket screening spirometer in diagnosing chronic obstructive pulmonary disease in general practice: a cross sectional validation study using tertiary care as a reference.
Labor M; Vrbica Ž; Gudelj I; Labor S; Plavec D
BMC Fam Pract; 2016 Aug; 17(1):112. PubMed ID: 27542843
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers].
Jaén Díaz JI; de Castro Mesa C; Gontán García-Salamanca MJ; López de Castro F
Arch Bronconeumol; 2003 Dec; 39(12):554-8. PubMed ID: 14636492
[TBL] [Abstract][Full Text] [Related]
16. Community pharmacy-based case finding for COPD in urban and rural settings is feasible and effective.
Fathima M; Saini B; Foster JM; Armour CL
Int J Chron Obstruct Pulmon Dis; 2017; 12():2753-2761. PubMed ID: 29075108
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting.
Fu SN; Yu WC; Wong CK; Lam MC
Int J Chron Obstruct Pulmon Dis; 2016; 11():2391-2399. PubMed ID: 27729780
[TBL] [Abstract][Full Text] [Related]
18. Comparison of forced expiratory volume in one second (FEV1) among asymptomatic smokers and non-smokers.
Khan A; Shabbir K; Ansari JK; Zia N
J Pak Med Assoc; 2010 Mar; 60(3):209-13. PubMed ID: 20225780
[TBL] [Abstract][Full Text] [Related]
19. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
Islam SS; Schottenfeld D
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
